IP Library Granted Patent US 9,409,000
Granted Patent B2
US 9,409,000 · App. 13/709,716 · Granted Aug 9, 2016

Balloon with fibers for treatment of blood vessels

Inventor: Barbara E. Stamberg (San Jose, CA)
Assignee: Abbott Cardiovascular Systems Inc.
A61M25/10A61M25/104A61M2025/105A61M2025/1081A61M2025/1086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,409,000
App. No.
13/709,716
Granted
Aug 9, 2016
Kind
B2
Abstract

The disclosed subject matter describes systems and methods of delivering a therapeutic agent, such as a sclerosing agent, to the walls of a blood vessel to perform sclerotherapy. In an exemplary embodiment a catheter includes a balloon having an inner and outer surface defining a wall, and an interior volume with an unexpanded and expanded configuration and a plurality of fibers extending from the outer surface of the balloon wall. In another exemplary embodiment, a balloon catheter comprises a catheter having a balloon with an unexpanded and an expanded configuration, and a retractable sheath disposed on the exterior surface of the balloon, wherein the sheath has an inner surface and an outer surface, and further wherein a plurality of fibers outwardly extend from the outer surface of the sheath.

Claims (15)

1. A balloon catheter comprising:

a catheter having at least one lumen extending therethrough;

a balloon having a body including an inner surface and an outer surface defining a balloon wall, wherein the body defines an interior volume in fluid communication with the at least one lumen and having an unexpanded configuration and an expanded configuration; and

a plurality of fibers extending from the outer surface of the balloon wall, wherein the fibers are sufficiently malleable to prevent damage to an intima of a blood vessel.

2. The balloon catheter of claim 1 , wherein the fibers are elongate and hollow.

3. The balloon catheter of claim 2 , wherein the fibers are configured to deliver a therapeutic agent.

4. The balloon catheter of claim 1 , wherein the balloon is constructed from biodegradable materials.

5. The balloon catheter of claim 1 , wherein the outer surface of the balloon is blood phobic.

6. The balloon catheter of claim 1 , wherein the outer surface of the balloon is alcohol phylic.

7. The balloon catheter of claim 1 further including an inflation fluid, wherein the inflation fluid includes a sclerosing agent.

8. The balloon catheter of claim 7 , wherein the sclerosing agent is ethanol.

9. The balloon catheter of claim 1 further comprising a sheath configured to be slidable over the balloon when the balloon is in the unexpanded configuration.

10. The balloon catheter of claim 9 , wherein the sheath is removable from the balloon prior to expansion.

11. The balloon catheter of claim 1 , where the balloon includes perforations through the balloon wall.

12. The balloon catheter of claim 1 , wherein the perforations are approximately 20 microns in diameter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2012
From: STAMBERG, BARBARA E.
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 029438/0513 →
Continuity (1)
Related Publication 20140163525A1 · Jun 12, 2014